MEDVECTORS™
Cart 0
Cart 0
MEDVECTORS™
The Precision Bioprocessing Platform

Gene therapy Everyone Can Process


Our next-gen Precision Bioprocess Platform supercharges development and production timelines for complex gene delivery to give more appropriate development production time and big ROI. For those interested in approaching our unique new space in CMO services, we are proud to offer the centerpiece technology for Medvectors featuring first in class real-time development powered by advanced machine learning algorithms.


MEDVECTORS™ is a biotech service company giving partners and clients fast and cost effective production and process development services for gene therapies and complex therapeutics.

AdobeStock_96817635.jpg

The Gene Therapy Industry… and us


When moving on future gene therapy territory including projects in gene cell production there are various complex problems that continue to effect the current market that many small to med-sized businesses are racing to solve.

  • As reported. the current processing timelines for new gene therapy projects for companies that need this service are reportedly now around 16 months (and still getting longer,) and, of course this makes those production process timelines much more costly while preventing any growth for more gene therapy developments.

  • Many established larger pharmaceutical companies while often financially able to construct or acquire facilities or build them in order to enable the development and manufacturing of these classes of treatments and development, may be looking for a new service such as Medvectors to provide more streamlined and less-costly development process and production data for very specific or smaller projects.

  • Mid-size to smaller companies involved will be significantly more reliant on services like Medvectors while trying to bring to market any new manufactured gene therapy projects.

  • Whether a small lab or established medicine, all partners of Medvectors gain a secure account for themselves directly connected to what is needed for “lab scale” components and functions, and process… and puts all of this directly at our client’s fingertips. These new systems greatly reduce manufacturing gaps and increases speed essentially to supercharging your own bioprocess timeline, and of course bring big ROI to production projects.

  • Our breakthrough Precision Bioprocess Platform gives digitally direct access for a new kind of monitoring and development platform using next-gen Viral Vectors Interfacing that allows for considerably more time-appropriate and cost-effectiveness when streamlining all development processes for optimal production and Big ROI.


Relevant Links with News Articles in context to the Medvectors Service:

Can gene cell therapy revolution scale?

Lack of CMO availability threatens cell gene therapy development


AdobeStock_4430604.jpeg

Our Philosophy


“Gene Therapy that Everyone can Process means we dream of using our biotech development and process data to revolutionize our unique space within precision medicine and healthcare, making rare and complex medicines truly more accessible to everyone.” - Medvectors Development Team

From single molecule, smaller virtual company’s… to large scale established pharmaceuticals... Medvectors can become a new precision bioprocessing partner for all regulatory ready solutions… all with Privacy and Security built into our platform’s DNA.

We do this by giving small to medium size biopharma companies access to their own platform that “supercharges” all development process time using inside of a next generation bioprocessing technology. For those interested in traversing this exciting new territory with us, we can be your new CMO service or partner of the future.

Privacy

Medvectors offers a truly Next Generation Biotechnology Processing Platform with trusted results. We understand everyone deserves a secure, private place to explore and understand their own research and development data and we have put this at the core of our philosophy. This means our client’s are in control of deciding what information they want to learn and what you want to secure or share.

Get Access to highly managed accounts that deliver the experience needed to build the best process for you. Our rigorous standards ensure quality science and service including:

  • Genetic Risk and Carrier Status reports that meet FDA criteria for being scientifically and clinically valid

  • All samples and processes within CLIA-certified in our CAP-accredited core lab

  • All sample data collection processes and reports are FDA-cleared for use with our reports

  • Our lab results are manufactured in accordance with FDA's Good Manufacturing Practice regulations

  • Our facility uses industry standard processes, and a well-established and reliable processing platform for analyzing gene therapy data across multiple already well-established and reliable processes and practices

  • Our team of scientists and biotech experts use a robust process to develop reports that ensure validity, and are available to chat with clients upon any questions or concerns throughout development.

  • Our report percentages and digital testing data is derived from our powerful, well-tested system that provides clients with processing data estimates down to the 0.1% 

The Current Gene Therapy Space, The future, and us…


“When moving on future gene therapy territory including projects in gene cell production there are various complex problems that continue to effect the current market that many small to med-sized businesses are racing to solve. This is exactly the problem Medvectors solves for you.”

- The Medvectors Development Team

  • As reported. the current processing timelines for new gene therapy projects for companies that need this service are reportedly now around 16 months (and still getting longer,) and, of course this makes those production process timelines much more costly while preventing any growth for more gene therapy developments.

  • Many established larger pharmaceutical companies while often financially able to construct or acquire facilities or build them in order to enable the development and manufacturing of these classes of treatments and development, may be looking for a new service such as Medvectors to provide more streamlined and less-costly development process and production data for very specific or smaller projects.

  • Mid-size to smaller companies involved will be significantly more reliant on services like Medvectors while trying to bring to market any new manufactured gene therapy projects.

  • Whether a small lab or established medicine, all partners of Medvectors gain a secure account for themselves directly connected to what is needed for “lab scale” components and functions, and process… and puts all of this directly at our client’s fingertips. These new systems greatly reduce manufacturing gaps and increases speed essentially to supercharging your own bioprocess timeline, and of course bring big ROI to production projects.

  • Our breakthrough Precision Bioprocess Platform gives digitally direct access for a new kind of monitoring and development platform using next-gen Viral Vectors Interfacing that allows for considerably more time-appropriate and cost-effectiveness when streamlining all development processes for optimal production and Big ROI.




Relevant Links with News Articles About Medvectors:

Can gene cell therapy revolution scale?

Lack of CMO availability threatens cell gene therapy development

AdobeStock_185833146.jpeg